This Health Research Initiatives Department is offering this grant to advance early-stage research into Alzheimer’s disease (AD), Alzheimer’s disease-related dementias (ADRD), and age-related cognitive decline. This funding opportunity is for the collection of pilot data supporting pharmacological and non-pharmacological interventions addressing cognitive and neuropsychiatric changes across the disease spectrum, from pre-symptomatic to severe stages. This grant is for the purpose of enabling researchers to test promising treatments and to stimulate studies aimed at enhancing clinical trial design and methodologies in these critical areas. The goal is to gather initial evidence to inform larger clinical trials, ultimately improving understanding and treatment strategies for these pervasive neurological conditions. This initiative supports foundational work crucial for developing effective interventions against cognitive impairment.
Opportunity ID: 345099
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAR-23-083 |
| Funding Opportunity Title: | Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.866 — Aging Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Dec 23, 2022 |
| Last Updated Date: | Dec 23, 2022 |
| Original Closing Date for Applications: | Nov 18, 2024 |
| Current Closing Date for Applications: | Nov 18, 2024 |
| Archive Date: | Dec 24, 2024 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $325,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Native American tribal governments (Federally recognized) For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts County governments State governments Native American tribal organizations (other than Federally recognized tribal governments) Private institutions of higher education City or township governments Special district governments Public and State controlled institutions of higher education Small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The purpose of this Funding Opportunity Announcement (FOA) is to 1) invite research grant applications that enable the collection of pilot data to support early stage testing of promising pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline and Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD) across the spectrum from pre-symptomatic to more severe stages of disease, and 2) stimulate studies to enhance trial design and methods. |
| Link to Additional Information: | https://grants.nih.gov/grants/guide/pa-files/PAR-23-083.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH Grants Information
grantsinfo@nih.gov Email:grantsinfo@nih.gov |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH Grants Information grantsinfo@nih.gov Email: grantsinfo@nih.gov |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-H | Use for due dates on or after January 25, 2023 | PKG00279036 | Jan 17, 2023 | Nov 18, 2024 | View |
Package 1
Mandatory forms
345099 RR_SF424_5_0-5.0.pdf
345099 PHS398_CoverPageSupplement_5_0-5.0.pdf
345099 RR_OtherProjectInfo_1_4-1.4.pdf
345099 PerformanceSite_4_0-4.0.pdf
345099 RR_KeyPersonExpanded_4_0-4.0.pdf
345099 RR_Budget_3_0-3.0.pdf
345099 PHS398_ResearchPlan_5_0-5.0.pdf
345099 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf
Optional forms
345099 RR_SubawardBudget30_3_0-3.0.pdf
345099 PHS_AssignmentRequestForm_3_0-3.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
